Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Practical Radiation Oncology|January 19, 2022
Cost-Effectiveness of Treatment Strategies for Spinal MetastasesRoman O Kowalchuk, Trey C Mullikin, Dong Kun Kim, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 21, 2019
Trends in the initial management of vestibular schwannoma in the United StatesJanet Leon, Daniel M Trifiletti, Mark R Waddle, et al.
Technical Innovations & Patient Support in Radiation Oncology|January 19, 2026
From BERT to GPT-4: A systematic review of AI-Driven toxicity extraction and grading in radiation oncologyFederico Mastroleo, Mariana Borras-Osorio, Shiv P Patel, et al.
Mayo Clinic Proceedings|June 25, 2019
Progress Toward Long-Term Survivors of GlioblastomaJ Nathan Cantrell, Mark R Waddle, Maarten Rotman, et al.
Advances in Radiation Oncology|February 2, 2019
Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial NeoplasmsKathryn R Fega, Geoffrey P Fletcher, Mark R Waddle, et al.
Journal of Oncology Practice|June 18, 2019
Identifying the Most Costly Patients in Radiation Oncology and Predicting the Top SpendersMark R Waddle, Tasneem A Kaleem, William C Stross, et al.
NPJ Digital Medicine|December 18, 2025
Personalizing prostate cancer education for patients using an EHR-Integrated LLM agentYuexing Hao, Jason Holmes, Mark R Waddle, et al.
American Journal of Clinical Oncology|September 22, 2025
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal AdenocarcinomaKeaton A Rummel, Christopher L Hallemeier, Zhaohui Jin, et al.
International Journal of Particle Therapy|June 3, 2024
Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate CancerRobert W Gao, Jiasen Ma, Thomas M Pisansky, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2017
Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured PatientsMark R Waddle, Terence T Sio, Holly K Van Houten, et al.
Pageof 6